Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to improved blood sugar control in ...
New study results could lead to better insurance coverage of the devices for people who don’t take insulin, a researcher said ...
Oura Ring uses Stelo by Dexcom to show glucose patterns, meal responses, and Time Above Range for users tracking blood sugar ...
DexCom, Inc. DXCM recently announced positive results from its CONNECT randomized controlled trial, demonstrating that use of ...
Dexcom and the FDA have announced a safety recall for people who bought two types of Dexcom G7 sensors from a third-party ...
A Dexcom continuous glucose monitor (CGM) helped adults with type 2 diabetes not using insulin improve blood sugar control in ...
DexCom, Inc. (NASDAQ:DXCM) announced today results from the CONNECT randomized controlled trial, demonstrating the use of ...
Some of Dexcom's continuous glucose monitoring receivers have been recalled due to speaker malfunctions, which can cause you to miss alerts or alarms for dangerous blood sugar levels. According to the ...
Dexcom warned that some lots of its G7 wearable glucose monitors were stolen on their way to the scrapyard and were sold by a ...
San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing just under ...
A new study presented at the American Diabetes Association found that Dexcom’s G7 continuous glucose monitor significantly ...
BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (CGM), is happy to share that people with type 1 diabetes who are ...